1.The Evaluation of Imaging Examination in the Diagnosis of Gastrointestinal Stromal Tumor
Jianbing SONG ; Jijun TANG ; Yingxing GUO ; Wanfeng TANG
Journal of Practical Radiology 2001;0(07):-
Objective To explore the imaging diagnostic value of gastrointestinal stromal tumor(GIST).Methods The retrospective study on GIST proved by operation and pathology in 11 cases was done.There were pneumobarium double contrast examination in 10 cases,CT scanning in 4 cases,superior mesenteric ateriography in 2 cases and fiberoptic endoscopy in 7 cases.Results The locations of tumors at gastric were 7 cases,intestinal 2,lipper and row oseophagus to gastric cardiac in 1,respectively.The detective rate of GIST was 100%,75%,100% and 100% respectively by pneumobarium double contrast examination,CT,arteriography and fiberoptic endoscopy.Conclusion Pneumobarium double contrast examination and fiberoptic endoscopy are important methods for diagnosis of GIST.CT and arteriography can better show the location of tumors and differential diagnosis of benign and malignant of tumor.
2.Astragalus for Heart Failure and Its Influence on TNF
Zhixin TANG ; Xinzhi HONG ; Wanfeng CHEN ; Bei LIU ; Yifu LI
China Pharmacy 2001;12(2):98-99
OBJECTIVE:To explore the possible mechanism of astragalus in improving cardiac function.METHODS:To observe the effects of astragalus,added to basic anti-heart-failure therapy,on cardiac function and TNF in 45 cases of thronic heart failure.RESULTS:In comparison with basic therapy group,the improvement of cardiac function was more obvious and the level of serum TNF-α was lower in astragalus group.CONCLUSION:Astragalus probably has the action of decreasing TNF resulting in improvement of cardiac function.
3.An investigation of ionizing radiation dose in a manufacturing enterprise of ion-absorbing type rare earth ore
Wanfeng ZHANG ; Shihao TANG ; Qiang TAN ; Yimin LIU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2016;34(8):620-622
Objective To investigate radioactive source term dose monitoring and estimation results in a manufacturing enterprise of ion-absorbing type rare earth ore and the possible ionizing radiation dose received by its workers.Methods Ionizing radiation monitoring data of the posts in the control area and supervised area of workplace were collected,and the annual average effective dose directly estimated or estimated using formulas was evaluated and analyzed.Results In the control area and supervised area of the workplace for this rare earth ore,α surface contamination activity had a maximum value of 0.35 Bq/cm2 and a minimum value of 0.01 Bq/cm2;β radioactive surface contamination activity had a maximum value of 18.8 Bq/cm2 and a minimum value of 0.22 Bq/cm2.In 14 monitoring points in the workplace,the maximum value of the annual average effective dose of occupational exposure was 1.641 mSv/a,which did not exceed the authorized limit for workers (5 mSv/a),but exceeded the authorized limit for general personnel (0.25 mSv/a).The radionuclide specific activity of ionic mixed rare earth oxides was determined to be 0.9.Conclusion The annual average effective dose of occupational exposure in this enterprise does not exceed the authorized limit for workers,but it exceeds the authorized limit for general personnel.We should pay attention to the focus of the radiation process,especially for public works radiation.
4.An investigation of ionizing radiation dose in a manufacturing enterprise of ion-absorbing type rare earth ore
Wanfeng ZHANG ; Shihao TANG ; Qiang TAN ; Yimin LIU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2016;34(8):620-622
Objective To investigate radioactive source term dose monitoring and estimation results in a manufacturing enterprise of ion-absorbing type rare earth ore and the possible ionizing radiation dose received by its workers.Methods Ionizing radiation monitoring data of the posts in the control area and supervised area of workplace were collected,and the annual average effective dose directly estimated or estimated using formulas was evaluated and analyzed.Results In the control area and supervised area of the workplace for this rare earth ore,α surface contamination activity had a maximum value of 0.35 Bq/cm2 and a minimum value of 0.01 Bq/cm2;β radioactive surface contamination activity had a maximum value of 18.8 Bq/cm2 and a minimum value of 0.22 Bq/cm2.In 14 monitoring points in the workplace,the maximum value of the annual average effective dose of occupational exposure was 1.641 mSv/a,which did not exceed the authorized limit for workers (5 mSv/a),but exceeded the authorized limit for general personnel (0.25 mSv/a).The radionuclide specific activity of ionic mixed rare earth oxides was determined to be 0.9.Conclusion The annual average effective dose of occupational exposure in this enterprise does not exceed the authorized limit for workers,but it exceeds the authorized limit for general personnel.We should pay attention to the focus of the radiation process,especially for public works radiation.
5.Investigation of a carbon monoxide poisoning accident with a hidden source
Shihao TANG ; Qiuyuan MAI ; Liping ZHOU ; Zhiqian YANG ; Wanfeng ZHANG ; Zhi WANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2023;41(8):619-622
In June 2022, a carbon monoxide poisoning accident with hidden source occurred in a bonded gold/silver wire manufacturing enterprise in Guangzhou, causing 10 people to be poisoned, of which 1 was caused by carbon monoxide poisoning and 9 by carbon monoxide contact reaction. The symptoms were dizziness, fatigue and vomiting. After 5 to 7 h, the saturation of carboxyhemoglobin in finger pulse was 4% to 10%, and the saturation of carboxyhemoglobin in blood gas biochemical analysis was 1.9% to 5.8%. The concentration of carbon monoxide detected in the carbon borne purification plant of the enterprise was 34.46-37.26 mg/m 3. It was judged that the accident was carbon monoxide poisoning caused by carbon monoxide gas being transported to the work post along the gas transmission pipeline due to abnormal operation of the carbon borne purification plant. By investigating the source and cause of poison, this paper provides a warning for the similar process to prevent similar events, and provides a new idea for the identification of chemical poisoning risk. At the same time, it is warned that similar enterprises should fully consider the risk of poisoning under specific circumstances, strengthen equipment maintenance and repair, and prevent the occurrence of similar incidents.
6.Sequential Treatment of Advanced Squamous Lung Cancer:First-line Gemcitabine+/-platinum Followed by Second-line Taxanes+/-platinum Versus Reverse Sequence
XU JING ; LIU XIAOQING ; GAO HONGJUN ; GUO WANFENG ; TANG CHUANHAO ; LI XIAOYAN ; LI JIANJIE ; QIN HAIFENG ; WANG WEIXIA ; QU LILI ; WANG HONG ; YANG HUI ; YANG LIN
Chinese Journal of Lung Cancer 2015;(5):308-314
Background and objective Gemcitabine and taxanes are effective agents commonly used in advanced squamous lung cancer. hTe best treatment sequence, however, is unclear to our knowledge. So we conducted this retrospective study in order to compare the effcacy and toxicities of ifrst-line Gemcitabine+/-platinum followed by second-line taxanes+/-platinum with the reverse sequence. Methods We totally analyzed 105 patients with stage IIIb-IV squamous lung cancer in our retrospective study. hTere were 49 patients receiving gemcitabine+/-platinum ifrst-line followed by taxanes+/-plati-num second-line (G-T group), and 56 patients receiving taxanes+/-platinum ifrst-line followed by gemcitabine+/-platinum second-line (T-G group). hTe primary endpoint of the study was overall survival (OS), and the secondary endpoints included progression-free survival (PFS), objective response rate (ORR), disease control rate (DCR) and toxicities. Results hTe me-dian OS were 18.5 mo in G-T group and 19.0 mo in T-G group (P=0.520). hTe median PFS1 was 5.0 mo and 4.0 mo with ifrst-line gemcitabine+/-platinum and taxanes+/-platinum, respectively (P=0.584). hTe median PFS2 was 2.7 mo and 2.5 mo with second-line gemcitabine+/-platinum and taxanes+/-platinum (P=0.432). hTe ORR1 of G-T group and T-G group were 36.73%and 33.92%(P=0.577), and DCR1 were 79.59%and 89.29%(P=0.186);the ORR2 of G-T group and T-G group were 4.08%and 5.36%(P=0.085), and DCR2 were 51.02%and 66.07%, respectively (P=0.118). Hematologic toxicities was more frequent in G-T group, the patients experienced more grade 3-4 lower hemoglobin (P=0.027) and thrombocytopenia (P=0.002). Conclusion hTe effcacy of ifrst line gemcitabine+/-platinum followed by second line taxanes+/-platinum and the reverse sequence was similar, and the toxicities was tolerable. Both sequential patterns were effective in advanced squamous lung cancer.
7.Investigation of a carbon monoxide poisoning accident with a hidden source
Shihao TANG ; Qiuyuan MAI ; Liping ZHOU ; Zhiqian YANG ; Wanfeng ZHANG ; Zhi WANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2023;41(8):619-622
In June 2022, a carbon monoxide poisoning accident with hidden source occurred in a bonded gold/silver wire manufacturing enterprise in Guangzhou, causing 10 people to be poisoned, of which 1 was caused by carbon monoxide poisoning and 9 by carbon monoxide contact reaction. The symptoms were dizziness, fatigue and vomiting. After 5 to 7 h, the saturation of carboxyhemoglobin in finger pulse was 4% to 10%, and the saturation of carboxyhemoglobin in blood gas biochemical analysis was 1.9% to 5.8%. The concentration of carbon monoxide detected in the carbon borne purification plant of the enterprise was 34.46-37.26 mg/m 3. It was judged that the accident was carbon monoxide poisoning caused by carbon monoxide gas being transported to the work post along the gas transmission pipeline due to abnormal operation of the carbon borne purification plant. By investigating the source and cause of poison, this paper provides a warning for the similar process to prevent similar events, and provides a new idea for the identification of chemical poisoning risk. At the same time, it is warned that similar enterprises should fully consider the risk of poisoning under specific circumstances, strengthen equipment maintenance and repair, and prevent the occurrence of similar incidents.
8.Comparison of Efifcacy and Safety of Different Therapeutic Regimens as Second-line Treatment for Small Cell Lung Cancer
LI ZHIHUA ; LIU XIAOQING ; LI JIANJIE ; GAO HONGJUN ; TANG CHUANHAO ; LI XIAOYAN ; GUO WANFENG ; QIN HAIFENG ; WANG WEIXIA ; QU LILI ; CHEN JIAN
Chinese Journal of Lung Cancer 2015;(5):280-288
Background and objective Small-cell lung cancer (SCLC) is an aggressive disease for which the mainstay of treatment is cytotoxic chemotherapy. Despite good initial responses most patients will relapse or progress atfer the ifrst-line therapy. hTe evidence of a beneift from second-line chemotherapy is limited in patients with relapsed/advanced SCLC. Some drugs are recommended by guidelines, but more regimens are formulated based on experience in clinical. So we conducted this retrospective study in order to compare the effcacy and safety of different second-line treatment regimens. Methods We totally analyzed 309 patients received second-line treatment in our retrospective study. 157 patients received best supportive care (BSC), and the rest 152 patients received second-line chemotherapy. hTe Kaplan-Meier method survival curves and Log-rank test were used to analysis the differences among different groups. hTe endpoints were objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), and overall survival (OS). Results Patients administered second-line chemotherapy lived signiifcantly longer, with a total OS from ifrst-line therapy of 11.5 mo compared to 6.0 mo in patients with best supportive care alone (P<0.001), and the ORR, DCR, PFS and OS of the former (including the sensitive dis-ease and resistance/refractory disease patients) were obviously better than that of the latter. hTe ORR and DCR of the patients who received second-line chemotherapy is 39.5%and 59.2%, respectively. hTe median PFS and OS from second-line chemo-therapy were 3.3 mo and 5.3 mo. hTe patients who received second-line chemotherapy were divided by types of second-line regimens. hTe sensitive disease patients were from group A (VP-16-based rechallenge) and group B1 (CPT-11-based regimen). hTe ORR of the two groups were 48.6%and 35.3%, and the DCR were 68.6%and 58.8%, respectively. hTere was no statistically signiifcant difference (P=0.264;P=0.400). hTe median PFS from second-line chemotherapy of the two groups were 4.0 mo and 3.0 mo, and the second-line median OS were 6.5 mo and 4.5 mo. hTere was no statistic difference (P=0.432;P=0.508). hTe resistance/refractory disease patients were divided into group B2 (CPT-11-based regimen), group C (PTX/DXL-based regi-men) and group D (TPT-based regimen). hTere was no statistic difference in second-line ORR, DCR and median PFS among the three groups (P value is 0.521, 0.528 and 0.775, respectively);hTe median OS from second-line chemotherapy of the group D is longer than that of group B2 and group C, with statistical difference (P=0.043;P=0.030). hTe differences of grade III-IV hematologic toxicities among the four subgroups were not statistically different. hTe incidence of diarrhea in non-hematologic toxicities in patients who received irinotecan as second-line chemotherapy was higher than other three subgroups (P=0.029). Conclusion Patients who progressed atfer the completion of ifrst-line chemotherapy can gain survival beneift. hTe response and the PFS of the different second-line chemotherapies were similar. hTe patients who received the TPT-based regimen may gain longer overall survival than other resistance/refractory disease patients.